MX2021004396A - Metodos y composiciones para el tratamiento de la mucositis oral. - Google Patents
Metodos y composiciones para el tratamiento de la mucositis oral.Info
- Publication number
- MX2021004396A MX2021004396A MX2021004396A MX2021004396A MX2021004396A MX 2021004396 A MX2021004396 A MX 2021004396A MX 2021004396 A MX2021004396 A MX 2021004396A MX 2021004396 A MX2021004396 A MX 2021004396A MX 2021004396 A MX2021004396 A MX 2021004396A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- oral mucositis
- treating oral
- treating
- Prior art date
Links
- 208000003265 stomatitis Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862746943P | 2018-10-17 | 2018-10-17 | |
| PCT/US2019/056772 WO2020081839A1 (en) | 2018-10-17 | 2019-10-17 | Methods and compositions for treating oral mucositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021004396A true MX2021004396A (es) | 2021-06-04 |
Family
ID=70281364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021004396A MX2021004396A (es) | 2018-10-17 | 2019-10-17 | Metodos y composiciones para el tratamiento de la mucositis oral. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11123357B2 (enExample) |
| EP (1) | EP3866810A4 (enExample) |
| JP (1) | JP2022503733A (enExample) |
| KR (1) | KR20210075968A (enExample) |
| CN (1) | CN112839662A (enExample) |
| AU (1) | AU2019361999A1 (enExample) |
| BR (1) | BR112021006954A2 (enExample) |
| CA (1) | CA3116157A1 (enExample) |
| IL (1) | IL282100A (enExample) |
| MX (1) | MX2021004396A (enExample) |
| SG (1) | SG11202103180QA (enExample) |
| WO (1) | WO2020081839A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12030908B2 (en) | 2017-03-10 | 2024-07-09 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
| US11795192B2 (en) * | 2017-03-10 | 2023-10-24 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
| WO2024129985A2 (en) * | 2022-12-14 | 2024-06-20 | Lakewood Amedex, Inc. | Antiviral compounds, compositions, and uses thereof |
| WO2025179296A1 (en) * | 2024-02-22 | 2025-08-28 | Lakewood Amedex, Inc. | Crystalline forms of nu-3 and uses thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4421769A (en) | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
| US5167950A (en) | 1991-03-28 | 1992-12-01 | S. C. Johnson & Son | High alcohol content aerosol antimicrobial mousse |
| CZ267396A3 (en) | 1994-03-11 | 1997-03-12 | Procter & Gamble | HYDROLYTIC STABLE COSMETIC, PREPARATION WITH LOW pH VALUE CONTAINING ACID ACTIVE SUBSTANCES |
| US6211162B1 (en) | 1998-12-30 | 2001-04-03 | Oligos Etc. Inc. | Pulmonary delivery of protonated/acidified nucleic acids |
| US20020032164A1 (en) | 1998-12-30 | 2002-03-14 | Dale Roderic M. K. | Antimicrobial compounds and methods for their use |
| US7868162B2 (en) | 1998-12-30 | 2011-01-11 | Lakewood-Amedex, Inc. | Antimicrobial and antiviral compounds and methods for their use |
| US6211349B1 (en) | 1998-12-30 | 2001-04-03 | Oligos Etc., Inc. | Protonated/acidified nucleic acids and methods of use |
| ES2234563T5 (es) | 1999-02-12 | 2018-01-17 | Daiichi Sankyo Company, Limited | Nuevos análogos de nucleósidos y oligonucleótidos |
| US6946118B1 (en) * | 1999-09-14 | 2005-09-20 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
| US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| JP2005511526A (ja) | 2001-10-18 | 2005-04-28 | イレックス プロダクツ インコーポレイテッド | ジホスホネート誘導体による皮膚の治療方法 |
| US20030236217A1 (en) * | 2002-05-21 | 2003-12-25 | Shalwitz Robert A. | Treatment of mucositis |
| CN1687100A (zh) * | 2005-04-05 | 2005-10-26 | 奥林格斯技术有限公司 | 修饰性核苷酸及其用途 |
| US8227431B2 (en) | 2008-03-17 | 2012-07-24 | Hetero Drugs Limited | Nucleoside derivatives |
| US8884000B2 (en) | 2010-02-17 | 2014-11-11 | Albert Einstein College Of Medicine Of Yeshiva University | Saporin-L1 inhibitors and uses thereof |
| WO2012017434A2 (en) * | 2010-08-03 | 2012-02-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Compounds for treating bacterial infections |
| AU2013264820A1 (en) * | 2012-05-23 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for treatment of mucositis |
| WO2014124430A1 (en) | 2013-02-11 | 2014-08-14 | Emory University | Nucleotide and nucleoside therapeutic compositions and uses related thereto |
| WO2015075406A1 (en) | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
| AU2015338969B2 (en) | 2014-10-30 | 2020-08-27 | Biomet Manufacturing, Llc | Methods of preventing surgical site infections |
| US10172786B2 (en) * | 2014-12-16 | 2019-01-08 | Axim Biotechnologies, Inc. | Oral care composition comprising cannabinoids |
| WO2017165673A1 (en) * | 2016-03-23 | 2017-09-28 | University Of Utah Research Foundation | Spinal traction device |
| KR102317158B1 (ko) * | 2017-03-10 | 2021-10-25 | 레이크우드 아메덱스, 인크. | 항미생물 화합물, 조성물, 및 그의 용도 |
| KR20260035292A (ko) * | 2017-06-12 | 2026-03-12 | 레이크우드 아메덱스, 인크. | 비스포스포신 겔 제제 및 이의 용도 |
-
2019
- 2019-10-17 BR BR112021006954-2A patent/BR112021006954A2/pt not_active Application Discontinuation
- 2019-10-17 JP JP2021515005A patent/JP2022503733A/ja active Pending
- 2019-10-17 MX MX2021004396A patent/MX2021004396A/es unknown
- 2019-10-17 SG SG11202103180QA patent/SG11202103180QA/en unknown
- 2019-10-17 KR KR1020217004939A patent/KR20210075968A/ko not_active Abandoned
- 2019-10-17 CA CA3116157A patent/CA3116157A1/en active Pending
- 2019-10-17 CN CN201980068116.XA patent/CN112839662A/zh active Pending
- 2019-10-17 US US16/656,129 patent/US11123357B2/en not_active Expired - Fee Related
- 2019-10-17 AU AU2019361999A patent/AU2019361999A1/en not_active Abandoned
- 2019-10-17 WO PCT/US2019/056772 patent/WO2020081839A1/en not_active Ceased
- 2019-10-17 EP EP19874581.2A patent/EP3866810A4/en not_active Withdrawn
-
2021
- 2021-04-06 IL IL282100A patent/IL282100A/en unknown
- 2021-08-27 US US17/459,248 patent/US20210393666A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022503733A (ja) | 2022-01-12 |
| WO2020081839A1 (en) | 2020-04-23 |
| BR112021006954A2 (pt) | 2021-07-20 |
| CA3116157A1 (en) | 2020-04-23 |
| CN112839662A (zh) | 2021-05-25 |
| AU2019361999A1 (en) | 2021-02-25 |
| SG11202103180QA (en) | 2021-05-28 |
| EP3866810A4 (en) | 2022-07-27 |
| US11123357B2 (en) | 2021-09-21 |
| US20210393666A1 (en) | 2021-12-23 |
| EP3866810A1 (en) | 2021-08-25 |
| KR20210075968A (ko) | 2021-06-23 |
| IL282100A (en) | 2021-05-31 |
| US20200121708A1 (en) | 2020-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
| MX2022004983A (es) | Composiciones de profarmaco y metodos de tratamiento. | |
| PH12019501970A1 (en) | Pharmaceutical compositions for combination therapy | |
| MX2021004396A (es) | Metodos y composiciones para el tratamiento de la mucositis oral. | |
| GB2541571A (en) | Pharmaceutical compositions | |
| WO2015148891A3 (en) | Dental device comprising surgical template and false teeth set and related methods | |
| EP4289820A3 (en) | Compounds for use in treating alzheimer's disease in apoe4+/+ patients | |
| PH12019501301A1 (en) | Pharmaceutical compositions for combination therapy | |
| MX2017002489A (es) | Agentes terapeuticos humanos. | |
| MX2020011817A (es) | Metodos para tratar el linfoma. | |
| MX2019014808A (es) | Aparato de muestreo bucal y usos de este. | |
| WO2019200314A3 (en) | Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof | |
| PH12020550462A1 (en) | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same | |
| JOP20220168A1 (ar) | طرق علاج الطحال | |
| CY1125113T1 (el) | Συνθεσεις και μεθοδοι για χρηση στην αγωγη της ομοκυστινουριας | |
| PH12018500254A1 (en) | Combinations of an ox40 antibody and a tlr4 modulator and uses thereof | |
| CY1119532T1 (el) | (s)-πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη | |
| TW201713323A (en) | Therapeutic compositions and methods of use thereof | |
| MX2020013389A (es) | Composiciones de terlipresina y usos de las mismas. | |
| PT3817689T (pt) | Dispositivo de cicatrização para implante dentário | |
| CY1119522T1 (el) | (r)- πιρλινδολη και τα φαρμακευτικως αποδεκτα αλατα αυτης για χρηση στην ιατρικη | |
| IL250852B (en) | Periodontal preparation | |
| MX2025015454A (es) | Formulaciones/composiciones que comprenden ibrutinib | |
| MX2024004013A (es) | Composiciones liquidas orales de enzalutamida. | |
| IL267081A (en) | Compounds, methods and devices for improving dental treatments |